SIEGEL GARY 4
4 · GENTA INC DE/ · Filed Jun 15, 2012
Insider Transaction Report
Form 4
GENTA INC DE/GNTA
SIEGEL GARY
Vice President, Finance
Transactions
- Award
Common Stock
2012-06-13+550,000,000→ 569,187,339 total
Footnotes (2)
- [F1]Restricted Stock grants subject to vesting requirements, including that the stock would vest 100% upon the approval by the U.S. Food and Drug Administration (FDA) of tesetaxel for any indication.
- [F2]Includes 19,187,339 shares of common stock potentially issuable upon the vesting of currently outstanding restricted stock units held by Mr. Siegel and 550,000,000 restricted shares issued pursuant to certain vesting requirements held by Mr. Siegel.